| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/25/2004 | US20040058344 Transgenic cells comprising precursor messenger RNA for diagnosis of infectious, cell proliferative, nervous system and metabolic disorders |
| 03/25/2004 | US20040058324 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040058316 Use of recombinant antigens to determine the immune status of an animal |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057927 Formulations for IL-11 |
| 03/25/2004 | US20040057925 Methods of enhancing bioactivity of chemokines |
| 03/25/2004 | DE3912046B4 Verfahren zum Markieren einer Komponente einer wäßrigen Flüssigkeit und lumineszenzphotostabiles Reaktionsprodukt A method of labeling a component of an aqueous liquid and the reaction product lumineszenzphotostabiles |
| 03/25/2004 | CA2499221A1 Rapidly degraded reporter fusion proteins |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498723A1 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 03/25/2004 | CA2498008A1 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | CA2498004A1 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | CA2498000A1 Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 03/25/2004 | CA2497661A1 Compositions and methods for the diagnosis of immune related diseases using pro71061 |
| 03/25/2004 | CA2497337A1 Novel composition and methods for the treatment of psoriasis |
| 03/24/2004 | EP1400593A1 Novel promoter |
| 03/24/2004 | EP1400592A1 Streptococcus pneumoniae polynucleotides and sequences |
| 03/24/2004 | EP1400536A1 Method for making humanized antibodies |
| 03/24/2004 | EP1400171A1 Transgenic production of antibodies in milk |
| 03/24/2004 | EP1399583A2 Compositions and methods relating to breast specific genes and proteins |
| 03/24/2004 | EP1399580A1 Secretion of proteins by encapsulated cells |
| 03/24/2004 | EP1399572A2 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 03/24/2004 | EP1399563A2 Moraxella (branhamella) catarrhalis antigens |
| 03/24/2004 | EP1399557A2 Brain expressed gene and protein associated with bipolar disorder |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399553A2 Polynucleotides encoding cellular transporters and methods of use therof |
| 03/24/2004 | EP1399552A2 G-protein coupled receptor proteins (gpcr) and nucleic acids encoding same |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399538A2 Engineering intracellular sialylation pathways |
| 03/24/2004 | EP1399484A2 Dual-specific ligand and its use |
| 03/24/2004 | EP1399483A2 Antibodies to insulin-like growth factor i receptor |
| 03/24/2004 | EP1399478A2 Cancer-testis antigens |
| 03/24/2004 | EP1399477A2 Process of purification of amyloid fibrils |
| 03/24/2004 | EP1399472A2 Soluble heterodimeric cytokine receptor |
| 03/24/2004 | EP1399110A2 Antibodies abolish prion propagation and promote clearance of infectivity |
| 03/24/2004 | EP1399016A2 Method for generating diversity |
| 03/24/2004 | EP0871736B1 PESTICIDAL COMPOSITION COMPRISING CryIF CHIMERIC AND CryIA(c) CHIMERIC BACILLUS THURINGIENSIS DELTA-ENDOTOXIN |
| 03/24/2004 | EP0796277B1 Fusion junction type iii mutant egf receptor peptide tumour vaccine |
| 03/24/2004 | EP0795015B1 Plasmids suitable for il-2 expression |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | EP0726953B1 Human kunitz-type protease inhibitors |
| 03/24/2004 | EP0625212B1 Methods of detecting alzheimer's disease |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484698A Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 03/24/2004 | CN1484694A Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484651A Production of recombinant BMP-2 |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484497A Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 03/24/2004 | CN1483831A Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges |
| 03/24/2004 | CN1483830A Method for preparing egg white peptide by enzyme method hydrolyzing egg white |
| 03/24/2004 | CN1483816A Colibacillns strain for recombination producing lectin of snowdrop and method thereof |
| 03/24/2004 | CN1483741A Novel human protein with cancer-suppressing function and coding sequence thereof |
| 03/24/2004 | CN1483740A Novel human protein with function for suppressing cancer and coding sequence thereof |
| 03/24/2004 | CN1483739A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1483738A Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710031 Protein having antithrombotic activity and method for producing the same |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709841 Generating preferential polypeptide; obtain cell, transform with vector coding preferential polypeptide, recover polypeptide |
| 03/23/2004 | US6709839 SYK-UBP proteins, compositions and methods of use |
| 03/23/2004 | US6709838 Nucleic acid encoding patched-2 |
| 03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
| 03/23/2004 | US6709833 Antibody for use as tool in immunoassay |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | CA2336207C Ecdysone receptors and methods for their use |
| 03/18/2004 | WO2004023509A2 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022754A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE |
| 03/18/2004 | WO2004022739A1 Antibody against n-terminal peptide or c-terminal peptide of gpc3 solubilized in blood |
| 03/18/2004 | WO2004022733A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 03/18/2004 | WO2004022720A2 Methods for identifying antimicrobial compounds |
| 03/18/2004 | WO2004022717A2 Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022698A2 Method for isolating and culturing unculturable microorganisms |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022597A1 Antibody against blood-solubilized n-terminal peptide in gpc3 |
| 03/18/2004 | WO2004022595A1 CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE |
| 03/18/2004 | WO2004022586A2 Tubulysin biosynthesis gene |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021797A1 Method for production of peptides/amino acids produced by said method and use of the same |
| 03/18/2004 | WO2004001042A3 Microarrays displaying encoded molecules |
| 03/18/2004 | WO2003102201A3 Methods and materials for the production of d-lactic acid in yeast |
| 03/18/2004 | WO2003087149A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003087148A3 Bacillus licheniformis mutant host cell |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003064608A3 Surface based translation system |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003004599A3 Methods of making and using expression constructs for the expression of recombinant proteins |